| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.400 | None | 0.941 | 34 | 0 | 1992 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.100 | None | 0.935 | 31 | 1 | 1992 | 2018 | ||||||||
|
CD38 molecule | 0.407 | 0.885 | 2.3E-06 |
|
disease | 0.100 | None | 1.000 | 24 | 2 | 1991 | 2015 | ||||||||
|
zeta chain of T cell receptor associated protein kinase 70 | 0.497 | 0.769 | 0.88 |
|
disease | 0.100 | None | 0.958 | 24 | 0 | 2003 | 2011 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
disease | 0.400 | None | 1.000 | 22 | 0 | 1998 | 2015 | ||||||||
|
CD19 molecule | 0.430 | 0.885 | 0.90 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 1992 | 2018 | ||||||||
|
immunoglobulin heavy variable 4-38-2-like | 0.514 | 0.769 |
|
disease | 0.100 | None | 1.000 | 14 | 0 | 1996 | 2012 | |||||||||
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 | 0.527 | 0.769 |
|
disease | 0.100 | None | 1.000 | 14 | 0 | 1996 | 2012 | |||||||||
|
Disrupted in B-cell neoplasia | 0.678 | 0.346 |
|
disease | 0.100 | None | 1.000 | 12 | 0 | 1995 | 2003 | |||||||||
|
Fc fragment of IgE receptor II | 0.560 | 0.654 | 7.6E-12 |
|
disease | 0.100 | None | 1.000 | 12 | 0 | 1991 | 2018 | ||||||||
|
immunoglobulin heavy variable 3-69-1 (pseudogene) | 0.561 | 0.654 |
|
disease | 0.100 | None | 1.000 | 12 | 0 | 1996 | 2012 | |||||||||
|
immunoglobulin heavy locus | 0.473 | 0.654 |
|
disease | 0.100 | None | 1.000 | 12 | 0 | 2000 | 2015 | |||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.090 | None | 1.000 | 9 | 1 | 1990 | 2015 | ||||||||
|
immunoglobulin heavy variable 3/OR16-7 (pseudogene) | 0.566 | 0.654 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 1996 | 2012 | |||||||||
|
deleted in lymphocytic leukemia 2 | 0.650 | 0.500 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 1997 | 2003 | |||||||||
|
keratin 20 | 0.388 | 0.846 | 9.1E-11 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1999 | 2017 | ||||||||
|
membrane spanning 4-domains A1 | 0.411 | 0.846 | 5.1E-05 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1999 | 2017 | ||||||||
|
RB transcriptional corepressor 1 | 0.444 | 0.885 | 1.00 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1993 | 2001 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1996 | 2009 | ||||||||
|
activation induced cytidine deaminase | 0.463 | 0.885 | 9.2E-06 |
|
disease | 0.060 | None | 0.833 | 6 | 0 | 2003 | 2008 | ||||||||
|
T cell leukemia/lymphoma 1A | 0.558 | 0.500 | 5.7E-10 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2006 | 2018 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.060 | None | 1.000 | 6 | 1 | 2000 | 2015 | ||||||||
|
deleted in lymphocytic leukemia 1 | 0.569 | 0.692 | 0.47 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1986 | 2002 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.060 | None | 0.833 | 6 | 0 | 1990 | 2006 | ||||||||
|
CD5 molecule | 0.682 | 0.308 | 2.3E-10 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1986 | 2005 |